Arkolith/Insider Trading/SUPN/Form 4

Mottola Frank

SVP, Chief Tech. Ops. OfficerSUPERNUS PHARMACEUTICALS, INC. (SUPN) · full profile →Form 4 · filed Mar 10, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$87K
Net Open-Market Flow
-$87K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 9, 2026Sell(S)2K$53.65$87K18K
Mar 6, 2026Tax withholding(F)2K$54.73$98K20K
Mar 6, 2026Option exercise(M)4K—$022K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 6, 2026Option exercise(M)4K—$00

Transaction Codes

S
Open-market sale
F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001804567-26-000010) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML